INTRODUCTION: We sought to evaluate the therapeutic effect of adi-pose tissue-derived stem cells (ADSCs) in a rat model of urethral fibrosis. METHODS: Eighteen (18) male Sprague-Dawley rats (300‒350 g) were divided into three groups: (1) sham (saline injection); (2) urethral fibrosis group (10 μg transforming growth factor beta 1 (TGF-β1) injection); and (3) ADSCs group (10 μg TGF-β1 injection plus 2 × 105 ADSCs). Rat ADSCs were harvested from rat inguinal fat pads. All study animals were euthanized at two weeks after urethral injection. Following euthanasia, rat urethral tissue was harvested for histologic evaluation. Type I and III collagen levels were quantitated by Western blot analysis. RESULTS: TGF-β1 injection induced significant urethral fibrosis and increased collagen type I and III expression (p<0.05). Significant decrease in submucosal fibrosis and collagen type I and III expression were noted in the ADSCs group compared with the urethral fibrosis group (p<0.05). TGF-β1 induced fibrotic changes were ameliorated by injection of ADSCs. CONCLUSIONS: Local injection of ADSCs in a rat model of urethral fibrosis significantly decreased collagen type I and III. These findings suggest that ADSC injection may prevent scar formation and potentially serve as an adjunct treatment to increase the success rate of primary treatment for urethral stricture disease. Further animal and clinical studies are needed to confirm these results.
INTRODUCTION: We sought to evaluate the therapeutic effect of adi-pose tissue-derived stem cells (ADSCs) in a rat model of urethral fibrosis. METHODS: Eighteen (18) male Sprague-Dawley rats (300‒350 g) were divided into three groups: (1) sham (saline injection); (2) urethral fibrosis group (10 μg transforming growth factor beta 1 (TGF-β1) injection); and (3) ADSCs group (10 μg TGF-β1 injection plus 2 × 105 ADSCs). Rat ADSCs were harvested from rat inguinal fat pads. All study animals were euthanized at two weeks after urethral injection. Following euthanasia, rat urethral tissue was harvested for histologic evaluation. Type I and III collagen levels were quantitated by Western blot analysis. RESULTS: TGF-β1 injection induced significant urethral fibrosis and increased collagen type I and III expression (p<0.05). Significant decrease in submucosal fibrosis and collagen type I and III expression were noted in the ADSCs group compared with the urethral fibrosis group (p<0.05). TGF-β1 induced fibrotic changes were ameliorated by injection of ADSCs. CONCLUSIONS: Local injection of ADSCs in a rat model of urethral fibrosis significantly decreased collagen type I and III. These findings suggest that ADSC injection may prevent scar formation and potentially serve as an adjunct treatment to increase the success rate of primary treatment for urethral stricture disease. Further animal and clinical studies are needed to confirm these results.
Authors: Premsant Sangkum; Ahmet Gokce; Ronny B W Tan; Mostafa Bouljihad; Hogyoung Kim; Sree Harsha Mandava; Sarmad N Saleem; George F Lasker; Faysal A Yafi; Zakaria Y Abd Elmageed; Krishnarao Moparty; Suresh C Sikka; Asim B Abdel-Mageed; Wayne J G Hellstrom Journal: J Urol Date: 2015-02-10 Impact factor: 7.450
Authors: E Alexsandro Da-Silva; Francisco J B Sampaio; M Cristina Dornas; Ronaldo Damiao; Luiz E M Cardoso Journal: J Urol Date: 2002-08 Impact factor: 7.450
Authors: Andre G Cavalcanti; Waldemar S Costa; Laurence S Baskin; Jack A McAninch; Francisco J B Sampaio Journal: BJU Int Date: 2007-08 Impact factor: 5.588
Authors: Juan José Rivera-Valdés; Jesus García-Bañuelos; Adriana Salazar-Montes; Leonel García-Benavides; Alfredo Dominguez-Rosales; Juan Armendáriz-Borunda; Ana Sandoval-Rodríguez Journal: PLoS One Date: 2017-12-27 Impact factor: 3.240